Triple-Negative Breast Cancer Part One: A Medical Update
- understand today’s standard of care treatments for triple-negative breast cancer
- learn the latest clinical trial findings
- gain a better understanding of new research directions
About Our Speaker
Rita Nanda, MD, is an assistant professor of medicine and associate director of the Breast Medical Oncology Program at the University of Chicago School of Medicine. She specializes in treating triple-negative, early onset, hereditary and locally-advanced breast cancers. Her research interests include identifying novel therapies that will improve outcomes for people with breast cancer.
She is a strong proponent of using chemotherapy prior to surgery, neoadjuvant chemotherapy, to better understand how an individual’s tumor responds to therapy.